Spots Global Cancer Trial Database for efficacy and safety
Every month we try and update this database with for efficacy and safety cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors | NCT03660761 | Efficacy and Sa... | apatinib temodar | 18 Years - 70 Years | Shandong Cancer Hospital and Institute | |
| HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer | NCT06383078 | Efficacy and Sa... | HR070803 Oxaliplatin Tegafur Folinic acid 5-Fluorouracil | 20 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC | NCT04284215 | Efficacy and Sa... | Albumin paclita... | 18 Years - 80 Years | Guizhou Medical University | |
| Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors | NCT03660761 | Efficacy and Sa... | apatinib temodar | 18 Years - 70 Years | Shandong Cancer Hospital and Institute | |
| Study of bb2121 in Multiple Myeloma | NCT02658929 | Multiple Myelom... | bb2121 | 18 Years - | Celgene | |
| Study of bb2121 in Multiple Myeloma | NCT02658929 | Multiple Myelom... | bb2121 | 18 Years - | Celgene | |
| Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer | NCT02785146 | Colorectal Canc... | Huaier Granule Oxaliplatin Calcium folinat... 5-fluorouracil | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC. | NCT03623776 | Efficacy and Sa... | JS001 Pemetrexed Carboplatin Thoracic Surger... | 18 Years - 75 Years | Sun Yat-sen University | |
| Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma | NCT03361748 | Multiple Myelom... | bb2121 | 18 Years - | Celgene | |
| Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer | NCT03955471 | Ovarian Neoplas... | Niraparib Dostarlimab | 18 Years - | Tesaro, Inc. | |
| A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX) | NCT02630368 | Solid Tumors Soft-tissue Sar... Breast Cancer | Cyclophosphamid... Cyclophosphamid... Cyclophosphamid... Avelumab and JX... | 18 Years - | Institut Bergonié | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer | NCT05481775 | Locally Advance... Efficacy and Sa... | Anlotinib Chemotherapy Radiotherapy Immunotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer | NCT05481775 | Locally Advance... Efficacy and Sa... | Anlotinib Chemotherapy Radiotherapy Immunotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma | NCT06218004 | Efficacy and Sa... | Envafolimab com... | 18 Years - 80 Years | Qianfoshan Hospital | |
| Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer | NCT03794778 | Efficacy and Sa... | pegylated lipos... paclitaxel Carboplatin | 18 Years - 75 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer | NCT02785146 | Colorectal Canc... | Huaier Granule Oxaliplatin Calcium folinat... 5-fluorouracil | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | NCT04518501 | Efficacy and Sa... | Arsenic trioxid... | 18 Years - 70 Years | Women's Hospital School Of Medicine Zhejiang University | |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT01648322 | Breast Cancer Neutropenia | F-627 Neulasta® (pegf... | 18 Years - 74 Years | EVIVE Biotechnology | |
| Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer | NCT02785146 | Colorectal Canc... | Huaier Granule Oxaliplatin Calcium folinat... 5-fluorouracil | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma | NCT06218004 | Efficacy and Sa... | Envafolimab com... | 18 Years - 80 Years | Qianfoshan Hospital | |
| The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | NCT02283476 | Lung Cancer | Endostar contin... Endostar routin... Gemcitabine Cisplatin | 18 Years - 75 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery | NCT02796820 | Colorectal Canc... | Huaier Granule | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma | NCT06218004 | Efficacy and Sa... | Envafolimab com... | 18 Years - 80 Years | Qianfoshan Hospital | |
| Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer | NCT06387368 | Pancreatic Canc... | Huaier Granule Capecitabine | 18 Years - | Health Science Center of Xi'an Jiaotong University | |
| Study of bb2121 in Multiple Myeloma | NCT02658929 | Multiple Myelom... | bb2121 | 18 Years - | Celgene | |
| Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer | NCT05481775 | Locally Advance... Efficacy and Sa... | Anlotinib Chemotherapy Radiotherapy Immunotherapy | 18 Years - 75 Years | Sun Yat-sen University | |
| Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy | NCT04727034 | Hypoxia Gastric Cancer Sedation Compli... Propofol Advers... | Remimazolam tos... Propofol | 18 Years - 60 Years | RenJi Hospital | |
| Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma | NCT06218004 | Efficacy and Sa... | Envafolimab com... | 18 Years - 80 Years | Qianfoshan Hospital | |
| Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim | NCT03255343 | Efficacy and Sa... | IMDENDRIM | 18 Years - 75 Years | French Association for the Advancement Medical Research | |
| Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy | NCT01648322 | Breast Cancer Neutropenia | F-627 Neulasta® (pegf... | 18 Years - 74 Years | EVIVE Biotechnology | |
| Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence | NCT04078399 | HSCT Efficacy and Sa... | Azacitidine com... | 14 Years - | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
